Major non-ABO incompatibility caused by anti-Jk ^a in a patient before allogeneic hematopoietic stem cell transplantation

1.Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000;96:1150–6.10.1182/blood.V96.3.1150Search in Google Scholar

2.Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2011;46:1167–85.10.1038/bmt.2011.13521897398Search in Google Scholar

3.Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763–71.10.1046/j.1537-2995.1999.39070763.x10413286Search in Google Scholar

4.Ramsey G, Larson P. Loss of red cell alloantibodies over time. Transfusion 1988;28:162–5.10.1046/j.1537-2995.1988.28288179022.x3354044Search in Google Scholar

5.Leo A, Mytilineos J, Voso MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk^aafter allogeneic PBPC transplantation. Transfusion 2000;40:632–6.10.1046/j.1537-2995.2000.40060632.x10864980Search in Google Scholar

6.Young PP, Goodnough LT, Westervelt P, Diersio JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:1305–10.10.1038/sj.bmt.170307411548850Search in Google Scholar

7.Adams BR, Miller AN, Costa LJ. Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2009;45:772–3.10.1038/bmt.2009.20219684635Search in Google Scholar

8.López A, de la Rubia J, Arriaga F, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998;38:247–51.10.1046/j.1537-2995.1998.38398222868.x9563404Search in Google Scholar

9.Perseghin P, Balduzzi A, Galimberti S, et al. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:231–6.10.1038/sj.bmt.170411412838290Search in Google Scholar

10.Borge PD, Stroka-Lee AH, Hsieh MM, et al. Delayed red blood cell chimerism in an HSC transplant for sickle cell disease associated with a non-ABO alloantibody (abstract). Transfusion 2010;50(Suppl 2):155A.Search in Google Scholar

11.Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361:2309–17.10.1056/NEJMoa0904971362753220007560Search in Google Scholar

12.Fenchel K, Bergmann L, Wijermans P, et al. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas. Leuk Lymphoma 1995;18:485–92.10.3109/104281995090596498528057Search in Google Scholar

13.Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857–61.10.1182/blood-2002-11-354712531800Search in Google Scholar

14.Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001;98:1687–94.10.1182/blood.V98.6.1687Search in Google Scholar